Martingale Asset Management L P Edwards Lifesciences Corp Transaction History

Martingale Asset Management L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $3.19 Million - $4.06 Million	-44,506 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $1.37 Million - $1.78 Million	20,350 Added 84.24%	44,506 $3.55 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $1.39 Million - $1.86 Million	24,156 New	24,156 $1.67 Million
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $2.02 Million - $2.7 Million	-42,207 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $1.64 Million - $2.02 Million	-35,405 Reduced 45.62%	42,207 $2.16 Million
Q3 2018 Nov 09, 2018	SELL	$45.7 - $58.03 $589,438 - $748,470	-12,898 Reduced 14.25%	77,612 $0
Q2 2018 Aug 09, 2018	SELL	$42.45 - $51.3 $1.49 Million - $1.8 Million	-35,179 Reduced 27.99%	90,510 $0
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $4.67 Million - $5.96 Million	125,689 New	125,689 $0

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.